Capital International Investors Illumina, Inc. Transaction History

Capital International Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$266.84 - $378.23 $227 Million - $321 Million	-849,899 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$300.59 - $368.15 $938 Million - $1.15 Billion	-3,120,469 Reduced 78.59%	849,899 $313 Million
Q1 2019 May 15, 2019	SELL	$272.57 - $321.18 $159,453 - $187,890	-585 Reduced 0.01%	3,970,368 $1.23 Billion
Q4 2018 Feb 14, 2019	SELL	$272.46 - $366.54 $18.7 Million - $25.2 Million	-68,814 Reduced 1.7%	3,970,953 $1.19 Billion
Q3 2018 Nov 14, 2018	BUY	$279.04 - $367.06 $1.13 Billion - $1.48 Billion	4,039,767 New	4,039,767 $1.48 Billion

913

139M

1.2M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $17.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.